Effects of all-trans retinoic acid on the human ovarian cancer HO8910 cell line

ZHAO Chun-quan; et al

您当前的位置：

首页 >

文章列表页 >

Effects of all-trans retinoic acid on the human ovarian cancer HO8910 cell line

更新时间：2024-01-17

- Effects of all-trans retinoic acid on the human ovarian cancer HO8910 cell line
- Journal of Chongqing Medical University Vol. 34, Issue 12, Pages: 1666-1669(2009)
- 作者机构：
  
  重庆医科大学附属第一医院妇产科
- 作者简介：
- 基金信息：
- DOI：
  CLC： R737.31
- Published：2009，
扫描看全文
[1]赵纯全,沈太敏.全反式维甲酸对人卵巢癌细胞株HO8910增殖、侵袭能力的影响[J].重庆医科大学学报,2009,34(12):1666-1669.

ZHAO Chun-quan, et al. Effects of all-trans retinoic acid on the human ovarian cancer HO8910 cell line. [J]. Journal of Chongqing Medical University 34(12):1666-1669(2009)
[1]赵纯全,沈太敏.全反式维甲酸对人卵巢癌细胞株HO8910增殖、侵袭能力的影响[J].重庆医科大学学报,2009,34(12):1666-1669. DOI：

ZHAO Chun-quan, et al. Effects of all-trans retinoic acid on the human ovarian cancer HO8910 cell line. [J]. Journal of Chongqing Medical University 34(12):1666-1669(2009) DOI：

摘要

目的:观察全反式维甲酸（All-trans retinoic acid

ATRA）对体外培养人卵巢癌细胞株HO8910增殖、侵袭能力的影响

为ATRA应用于卵巢癌的临床治疗提供实验依据。方法:选用人卵巢癌细胞株HO8910进行体外培养

以不同浓度的ATRA处理HO8910细胞

四甲基偶氮唑蓝（MTT）比色法检测细胞增殖抑制情况

倒置显微镜进行形态学观察

Transwell小室体外侵袭实验检测细胞侵袭能力。结果:（1）ATRA浓度为10-7～10-5mol/L时

均明显抑制HO8910细胞的增殖（P<0.05）

并具有时间-剂量依赖性。24、48、72hATRA抑制HO8910细胞增殖的IC50值分别为2.331×10-5、0.998×10-6、0.891×10-7mol/L。（2）倒置显微镜可观察到经10-6mol/LATRA处理的HO8910细胞部分发生形态学的良性分化。（3）体外侵袭实验显示经10-6mol/LATRA处理的HO8910细胞

穿膜细胞数目明显减少（P<0.05）。结论:ATRA能明显抑制人卵巢癌细胞株HO8910的增殖、侵袭能力

有望为ATRA应用于卵巢癌的临床治疗提供新的有效的途径。

Abstract

Objective:To investigate the effects of all-trans retinoic acid on the human ovarian cancer cell line HO8910.Methods:The human ovarian cancer cell line HO8910 cultured in vitro were treated with various concentrations of all-trans retinoic acid.The cell proliferation inhibition was detected by MTT assay;The morphologic changes of cell differentiation were observed under inverted microscope;The invasion capability was evaluated by transwell chambers.Results:1.ATRA of 10-7～10-5mol/L inhibited the proliferation of HO8910 cell significantly in a dose-dependent and time-dependent manner(P<0.05)and its IC50 were 2.331×10-5 mol/L、0.998×10-6 mol/L、0.891×10-7 mol/L at 24 hours、48 hours and 72 hours

separately.2.Treated by 10-6 mol/L ATRA

HO8910 cells showed striking morphological characteristics of differentiation under microscope.3.The number of invasive cells decreased significantly after treated by 10-6 mol/L ATRA(P<0.05).Conclusion:ATRA can both inhibit the proliferation and invasion of human ovarian cancer cell line HO8910

Which expect to provide an effective and novel approach for clinical treatment of human ovarian cancer.

关键词

全反式维甲酸卵巢癌增殖侵袭

Keywords

all-trans retinoic acidovarian carcinomaproliferationinvasion

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Impacts of LncRNA MYLK-AS1 on proliferation，apoptosis，and invasion of gastric cancer cells by regulating the miR-141-3p/STMN1 axis

Proteasome activator subunit 1/2 promotes the proliferation and invasion of endometrial carcinoma cells by inhibiting the expression of cyclin-dependent kinase 15

Effects of silencing Cyclophilin A by siRNA on proliferation and metastasis in Hep-2 cells

Effect of GRASP65 expression on proliferation,apoptosis,migration and invasion of gastric cancer cells

Experimental study of Artemin on proliferation and invasion of pancreatic ductal adenocarcinoma cell line

Related Author

Liu Jie

Xie Xingming

Niu Hongxia

Yang Xianzhi

Zhang Hailin

Li Cong

Xiao Zhenghua

Liao Juan

Related Institution

Department of Gastrointestinal Surgery，The Third Affiliated Hospital of Zunyi Medical University/ The First People’s Hospital of Zunyi

Department of Obstetrics and Gynecology,Yongchuan Hospital Affiliated to Chongqing Medical University

Department of Obstetrics and Gynecology,The First Affiliated Hospital of Chongqing Medical University

Central Laboratory of Yongchuan Hospital Affiliated to Chongqing Medical University

Department of Otolaryngology,The First Affiliated Hospital of Chongqing Medical University

⁰